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Most colorectal cancers are diagnosed after the onset of symptoms. However, the risk of colorectal cancer posed by particular
symptoms is largely unknown, especially in unselected populations like primary care. This was a population-based case–control study
in all 21 general practices in Exeter, Devon, UK, aiming to identify and quantify the prediagnostic features of colorectal cancer. In total,
349 patients with colorectal cancer, aged 40 years or more, and 1744 controls, matched by age, sex and general practice, were
studied. The full medical record for 2 years before diagnosis was coded using the International Classification of Primary Care-2. We
calculated odds ratios for variables independently associated with cancer, using multivariable conditional logistic regressions, and then
calculated the positive predictive values of these variables, both individually and in combination. In total, 10 features were associated
with colorectal cancer before diagnosis. The positive predictive values (95% confidence interval) of these were rectal bleeding 2.4%
(1.9, 3.2); weight loss 1.2% (0.91, 1.6); abdominal pain 1.1% (0.86, 1.3); diarrhoea 0.94% (0.73, 1.1); constipation 0.42% (0.34, 0.52);
abnormal rectal examination 4.0% (2.4, 7.4); abdominal tenderness 1.1% (0.77, 1.5); haemoglobin o10.0 g dl1 2.3% (1.6, 3.1);
positive faecal occult bloods 7.1% (5.1, 10); blood glucose410 mmol l1 0.78% (0.51, 1.1): all Po0.001. Earlier diagnosis of colorectal
cancer may be possible using the predictive values for single or multiple symptoms, physical signs or test results.
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Colorectal cancer is common worldwide, with over 30 000 new
cases in the UK annually (Quinn et al, 2001). Survival from
colorectal cancer in the UK is worse than in many other countries
(Gatta et al, 2000a, 2003) One explanation for this may be delays
in diagnosis (Gatta et al, 2000b). Such diagnostic delays may be
reduced by a proposed national programme of screening, which
has begun in pilot regions. This screening programme initially
targeted those aged 50–70, with less than 60% of those invited
actually participating (UK Colorectal Cancer Screening Pilot
Group, 2004). Most colorectal cancers are diagnosed in patients
over the age of 70, so it is likely that screening will only identify
around a quarter of total colorectal cancers. Similar figures pertain
in the USA, with screening recommended for those aged over 50
years (US Preventive Services Task Force, 2002), but less than half
of the population have actually had a screening procedure (Seeff
et al, 2002). Therefore, most colorectal cancers are diagnosed after
symptoms have developed. This is likely to continue.
Presentation with symptoms is usually to primary care, yet most
research on the symptoms of colorectal cancer has studied patients
in secondary care (MacArthur and Smith, 1984; Kyle et al, 1991;
Curless et al, 1994). The prediagnostic features in primary care (or
any other unselected population) differ from those in secondary
care, with different sensitivities, specificities and predictive values
(Summerton, 2002). These parameters are largely unknown for the
clinical features of colorectal cancer in primary care (Hamilton
and Sharp, 2004), with positive predictive values only reported
for rectal bleeding, 3.3 and 7% in two studies (Fijten et al, 1995;
Wauters et al, 2000); and anaemia, 7.4% in one study (Logan et al,
2002). These features of cancer were examined individually in
these studies, and the influence of additional symptoms on the risk
of cancer has not been reported.
Once colorectal cancer is suspected, the diagnosis can only be
established (or refuted) by examining the large bowel, usually by
colonoscopy. This is a specialist procedure, requiring considerable
investment in resources and training. Furthermore, it requires
preparation of the bowel, and sedation, and has a small risk of
complications, such as perforation (Robinson et al, 1999). In the
UK, doctors who believe their patient may have a colorectal cancer
can access investigation by referral to a 2-week clinic. This clinic
promises rapid investigation of the suspected cancer. Referrals are
aided by the Referral Guidelines for Suspected Cancer, which
specify clinical features associated with cancer (Department of
Health, 2000). However, the evidence base for these guidelines is
weak (Hamilton and Sharp, 2004), and the majority of patients
with cancer are diagnosed outwith the 2-week clinics (Boulton-
Jones et al, 2003; Flashman et al, 2004). Furthermore, one risk of
guidelines is that they may identify only typical presentations of
cancer, whereas atypical presentations may represent early
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cancers, and hence may have the most to benefit from early
diagnosis (Jones et al, 2001). Against this background, we sought
to identify and quantify the features of colorectal cancer occurring
before the diagnosis is made.
METHODS
Subjects
This was a population-based case–control study, involving all 21
general practices in Exeter, Devon, UK. The total population of
Exeter in mid-2000 was 128 700, of whom 60 548 were aged 40 years
or over. All patients aged 40 years or over with a primary colorectal
cancer, diagnosed from 1998 to 2002, were identified from the
cancer registry at the Royal Devon and Exeter Hospital. This
register collects registrations from three main sources: direct
notifications by clinicians, routine notification of all positive
histology results and forwarding of patient lists from the oncology
treatment centre. All histology and oncology treatment for Exeter
patients is performed at the Royal Devon and Exeter Hospital. The
register is subjected to internal and external validation procedures,
and is believed to have identified over 95% of local cancers.
Computerised searches at every practice identified any cases
missing from the cancer register. Cases without positive histology
were included if the records contained a specialist diagnosis of
cancer based on strong clinical evidence. The date of diagnosis was
taken as the date of positive histology or as given by the specialist
in those without histology.
Five controls were matched to each case on sex, general practice,
and age (to 1-year bands if possible, increased in 1-year multiples
to a maximum of 5 years). The choice of five controls to each case
was a balance between maximising power against decreasing
efficiency. Controls were eligible if they were alive at the time of
diagnosis of their case: this did not preclude their being dead at the
time of study. Exclusion criteria for both cases and controls were:
unobtainable records; no consultations in the 2 years before
diagnosis; previous colorectal cancer; or residence outside Exeter
at the time of diagnosis. Ineligible controls were replaced by
randomly selected reserves. If an ineligible control was dead at the
time of study, a reserve control, also dead, was used.
Collection and coding of medical data
We made anonymised photocopies of the full primary care records
for 2 years before diagnosis. Four research assistants, blinded to
case/control status, coded all entries using the International
Classification of Primary Care-2 (ICPC) (WONCA, 1998). This is
the most symptom-based of the common coding systems (de
Lusignan et al, 2001). Additional codes were created to incorporate
all possible clinical features. Within a given general practice the
same researcher coded both cases and controls, so that any
interobserver variation in coding style would affect both cases and
their matched controls equally. Ethical approval was obtained from
North and East Devon local research ethics committee.
Analysis
Identification of independent associations with cancer Only
variables occurring in at least 2.5% of either cases or controls
were analysed. Differences between cases and controls were
analysed using conditional logistic regression. Variables associated
with cancer in univariable analyses, using a P-value of 0.1 or less,
entered the multivariable analysis. This was performed in stages,
first collecting similar variables together, such as those which
could represent anaemia. These were then analysed to identify
variables to progress to the second stage. These variables were
re-grouped into symptoms, signs and investigations. Further
multivariable analyses were then performed, first of the variables
within these new groups, and then of all those variables ‘surviving’
the second stage. Using this approach, a final model was derived
including all the variables independently associated with colorectal
cancer. All discarded variables were then checked against the final
model. Finally, 18 clinically plausible interactions were tested in
the final model. Analyses were repeated excluding data from the
last 180 days of the 730 day period studied.
Calculation of positive predictive values This was possible
because we had identified all cases occurring in the population.
Positive predictive values for individual variables and for pairs
of variables were calculated from the likelihood ratio and the
observed incidence of cancer during the study (Knottnerus,
2002). As all cases had consulted in primary care, but 5.6% of
initially selected controls had not, predictive values were divided
by 0.944 to give the predictive value for the consulting population.
Confidence intervals for these were calculated using Markov Chain
Monte Carlo methods in Winbugs (Spiegelhalter et al, 2003).
Stratified analyses by age (over and under 70 years) were
performed for individual features, but these were not performed
if any cell in the 2 2 table was below 10.
Sample size calculations Sample size calculations used an
estimated 350 cases. With this number, five controls per case
were required to provide 90% power to identify a change in a rare
variable from 5% prevalence in one group to 10% in the other,
using a two-sided 5% alpha. This number had 94% power to
identify a change in a common variable from 30% to 40%.
Analyses were performed using Stata, version 8 (StataCorp, 2001).
RESULTS
Cases and controls
In total, 379 cases were identified from the cancer registry (376)
and practice searches (3). A total of 30 were ineligible: 10 of these
had previous colorectal cancer; five were unconfirmed cancers;
three resided outside Exeter at diagnosis; and in 12 the records
were unobtainable (seven had left Exeter, five had died). A total of
1744 matched controls were studied (in one elderly case only four
controls were available in the maximum 5 year age band). In total,
1980 controls were originally generated, but 236 were ineligible: 22
had previous colorectal cancer; 111 (5.6%) had not consulted in
the 2 years; 19 resided outside Exeter; and in 84 the records were
unobtainable (77 had left Exeter, seven had died). These totals
include 141 (40%) cases and 138 (7.9%) of controls who had died
but whose notes were retrievable. In three cases, a clinical
diagnosis of cancer was made but initial biopsies were negative.
Positive histology was obtained later. For these, the date of
diagnosis was changed to the date of the initial biopsy, 39–63 days
earlier.
Of the 349 cases studied, 210 (60.2%) had tumours at or distal
to the splenic flexure, and 126 (36.1%) proximal to it, with the
remaining 13 (3.7%) in multiple or unknown sites. Duke’s staging
was known for 305 : 170 (48.7%) were Duke’s A or B, and 135
(38.7%) Duke’s C or D. Demographic and medical care details are
shown in Table 1. For all consultation and code measures in
Table 1 there was strong evidence of higher occurrence in cases
than controls: Po0.001.
Quality of coding
Interobserver variation in coding was examined by randomly
selecting 188 codes. All four coders then coded the same records.
The reliability coefficient was 0.83 (95% confidence interval 0.75,
0.90) (Streiner and Norman, 2003).
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Identification of independent associations with cancer
In total, 121 variables occurred in 2.5% or more of either cases
or controls. From univariable conditional logistic regressions, 56
variables were considered for multivariable analyses. Selected
univariable analyses are shown in Table 2. All variables in Table 2
were more common in cases: P-values o0.001 for all except
history of diabetes, with P¼ 0.01. Low haemoglobin results were
split into three sub-categories regardless of sex: 12.9–12.0,
11.9– 10.0 and o10.0 g dl1. As well as conferring advantages of
simplicity, this was appropriate given that the difference between
the sexes in haemoglobin level diminishes markedly once women
are postmenopausal, which will have been the case for almost
all those in this study (Guralnik et al, 2004). In any case, the
multivariable analysis investigated the interaction between haemo-
globin subcategory and sex.
Multivariable analyses
One ICPC code, ‘change in bowel habit,’ was excluded from
modelling. This term implies constipation, diarrhoea or a
combination of the two. However, when used in the UK, the
phrase has connotations of suspected colorectal cancer over and
above its literal meaning: the specific codes for constipation and
diarrhoea were used instead.
The numbers of consultations with abdominal pain or diarrhoea
followed a dose–response relationship with cancer, with the risk
increasing up to the third consultation for abdominal pain and the
fifth consultation for diarrhoea. These two variables were therefore
kept as discrete numerical variables. The code for anal/rectal pain
was associated with cancer in univariable analysis, but not so in
any multivariable analyses that included rectal bleeding. Of the 349
cases, 327 had at least one of the variables from Table 3, leaving 22
cases who had none of the features. In contrast, only 532 of the
1744 controls had at least one.
There was an interaction (P¼ 0.016) between haemoglobin
subcategory and age group, whereby the association between
anaemia and cancer was stronger among younger patients. To
illustrate this, the likelihood ratios (95% confidence interval (CI))
for the younger age group (aged 40 –69) were haemoglobin 12.9–
12.0 g dl1, 15 (6.8, 33), haemoglobin 11.9– 10.0 g dl1, 17 (10, 29)
and haemoglobin o10 g dl1, 13 (6.7, 27). For patients aged over
70 years the likelihood ratios were 3.1 (1.7, 5.5), 2.7 (1.8, 3.9), and
8.9 (6.4, 12), respectively. Including this interaction in the model
made virtually no difference to its performance in terms of risk
prediction and would have made it considerably more complex;
hence, it was omitted from the model presented in Table 3.
Table 1 Characteristics of colorectal cancer cases and matched controls
Characteristic
Cases
(N¼ 349 (%))
Controls
(N¼ 1744 (%))
Age at diagnosis
o60 45 (12.9) 225 (12.9)
60–69 97 (27.8) 487 (27.9)
70–79 113 (32.4) 555 (31.8)
80+ 94 (26.9) 477 (27.4)
Sex
Male 177 (50.7) 885 (50.7)
Median (interquartile range)
Number of consultations per patient
In the two years 15 (8–22) 10 (5–17)
Excluding last 180 days 9 (4–15) 7 (4–13)
Number of ICPC codes per patient
In the two years 33 (19–50) 19 (10–33)
Excluding last 180 days 18 (7–31) 13 (7–24)
Table 2 Univariable analyses of selected variables
Number (%) with this
variable present
Variable
Cases
(n¼ 349)
Controls
(n¼ 1744)
Positive
likelihood
ratio (95% CI)
Symptoms
Rectal bleeding 148 (42.4) 73 (4.2) 10 (7.9, 13)
Loss of weight 94 (26.9) 92 (5.3) 5.1 (3.9, 6.6)
Abdominal pain 148 (42.4) 163 (9.4) 4.5 (3.8, 5.5)
Diarrhoea 132 (37.8) 171 (9.8) 3.9 (3.2, 4.7)
Constipation 91 (26.1) 258 (14.8) 1.8 (1.5, 2.1)
Physical signs
Rectal disease on rectal
examination
51 (14.6) 14 (0.80) 18 (10, 32)
Tenderness on palpation
of abdomen
62 (17.7) 67 (3.8) 4.6 (3.3, 6.4)
Investigations
Positive faecal occult
blooda
31 (8.9) 5 (0.3) 31 (22, 43)
Haemoglobin 12–
12.9 g dl1
17 (4.9) 20 (1.2) 4.3 (2.7, 6.8)
Haemoglobin 10–
11.9 g dl1
38 (10.9) 49 (2.8) 3.9 (2.8, 5.2)
Haemoglobin o10 g dl1 40 (11.5) 21 (1.2) 9.5 (7.1, 13)
Blood sugar 410 mmol l1 25 (7.1) 39 (2.2) 3.2 (2.2, 4.7)
Miscellaneous
History of diabetes 37 (10.6) 119 (6.8) 1.6 (1.2, 2.1)
aFrom the 79 (23%) cases and 47 (3%) controls who had been tested.
Table 3 Multivariable conditional logistic regression analysis of pre-
diagnostic features of colorectal cancer
Variable Odds ratio 95% CI P-value
Symptoms
Rectal bleeding 15 9.0, 24 o0.001
Loss of weight 2.7 1.7, 4.6 o0.001
Number of episodes of abdominal paina 2.2b 1.7, 2.8 o0.001
Constipation 2.0 1.2, 3.3 0.006
Number of episodes of diarrhoea 1.6b 1.3, 2.0 o0.001
Signs
Rectal disease on rectal examination 13 4.7, 37 o0.001
Tenderness on palpation of abdomena 3.6 1.7, 7.8 0.001
Investigations
Positive faecal occult blooda 81 20, 330 o0.001
Low haemoglobin, category o0.001
No low haemoglobin 1
Haemoglobin 12.0–12.9 g dl1 2.5 0.95, 6.8
Haemoglobin 10.0–11.9 g dl1 4.3 2.1, 9.0
Haemoglobin o10 g dl1a 13 6.2, 28
Blood sugar 410 mmol l1 2.0 1.3, 3.1 0.001
Interaction terms
Abdominal pain with tenderness 0.56 0.38, 0.82 0.003
Positive FOBs with haemoglobin o10 g dl1 0.020 0.0015, 0.27 0.003
aVariables that have interactions. bFor each consultation with this symptom.
Clinical features of colorectal cancer
W Hamilton et al
401
British Journal of Cancer (2005) 93(4), 399 – 405& 2005 Cancer Research UK
C
li
n
ic
a
l
S
tu
d
ie
s
Two antagonistic interactions were retained in the final model:
abdominal pain with abdominal tenderness, and positive faecal
occult bloods with a haemoglobino10 g dl1. These interactions
reflect the fact that the combined effect of, for example, both
positive faecal occult bloods and low haemoglobin together is less
than that which would be expected by simple multiplication of
the odds ratios in Table 3. There were no interactions with sex,
supporting the decision to use the same haemoglobin subcate-
gories for both sexes.
Timing of variable occurrence and analysis excluding the
last 180 days
Multivariable analysis using data excluding the last 180 days is
shown in Table 4. The timings of the five variables from Table 4,
in relation to the date of diagnosis, are shown in Figure 1. These
graphs compare the monthly moving average number of
presentations to primary care for each variable.
Positive predictive values for patients consulting a doctor
in primary care
The positive predictive values for clinical features are shown in
Figure 2, both individually and together with a second variable.
The variables chosen were those from the multivariable analysis in
Table 3, apart from a raised glucose or a positive faecal occult
blood, as these had small numbers. Haemoglobin values between
12.9 and 10.0 g dl1 were merged for this analysis, as their
likelihood ratios were similar.
The positive predictive values of the following features were
higher for older patients: abdominal pain 0.65% aged 40– 69, 2.0%
aged 70 or over; diarrhoea 0.63 and 1.7%; constipation 0.2 and
1.3%; rectal bleeding 1.4 and 4.8%; and loss of weight 0.74 and
2.5%, respectively. There were too few patients aged 40– 69 with
the other variables for reliable analysis.
DISCUSSION
We found 10 symptoms, signs or investigation results to be
independently associated with colorectal cancer. Five of these
remained associated with cancer 180 days before diagnosis. As well
as identifying these features, we were able to quantify the risk they
pose, both alone and in combination.
Study strengths and weaknesses
This is the first study to examine all the prediagnostic features of
colorectal cancer together. We were also able to study many more
Table 4 Multivariable conditional logistic regression analysis of pre-
diagnostic features of colorectal cancer excluding the final 180 days
Variable Odds ratio 95% CI P-value
Symptoms
Rectal bleeding 3.0 1.9, 4.9 o0.001
Abdominal pain 2.3 1.6, 3.2 o0.001
Investigations
Positive faecal occult blood 5.4 1.2, 25 0.029
Low haemoglobin, category o0.001
No low haemoglobin 1
Haemoglobin 12.0–12.9 g dl1 2.3 1.2, 4.3
Haemoglobin 10.0–11.9 g dl1 3.0 1.8, 5.0
Haemoglobin o10 g dl1 7.1 3.7, 14
Blood sugar 410 mmol1l1 1.8 1.4, 2.4 o0.001
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Figure 1 Timing of symptom presentation to primary care in cases and controls. Time 0 is the date of diagnosis in the case. Results presented as monthly
moving average. Upper line¼ cases, lower¼ controls. Y-axis has different scales.
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cases than in previous reports of single clinical features from
primary care (Fijten et al, 1995; Wauters et al, 2000; Logan et al,
2002). Furthermore, as every general practice in Exeter partici-
pated in the study, we could identify all the cases occurring in a
well-defined population, and studied almost all of them. The
Dendrite Register is believed to be very complete: this view is
supported by the fact that only three additional cases were found
on practice searches. Practice recordkeeping was also good, as
shown by our separate study of the quality of the notes (Hamilton
et al, 2003). We were also able to estimate the proportion of the
population consulting with their doctor, and thus could calculate
positive predictive values for the consulting population. However,
by only studying patients who had consulted, our results do not
provide the frequency or the predictive values of symptoms in the
general population. This may not matter, in that the study was
stationed where the clinical problem exists: when to investigate a
patient who has a problem that may represent colorectal cancer.
The first potential weakness of the study is that recording of
symptoms and signs may vary between practices. This is less of an
issue for test results, as these were extracted directly from the
laboratory printout. It is possible that doctors record symptoms
more thoroughly if they consider cancer a possibility. If this is the
case, the positive predictive values in this study will have been
overestimated. The converse – of more recording of symptoms
when no diagnosis is apparent – is also possible, but less likely.
The matched design will have partly compensated for such
variations in testing and recording.
However, matching can be a weakness too. By matching, the
ability to study the matched variable directly is lost. The two major
factors affecting primary care consultation rates are age and sex
(McCormick et al, 1995). These had to be matched for, and the
final decision to select randomly from a 1-year age band was a
careful balance between insufficient and over-matching. The third
factor we matched was the general practice. This was to reduce bias
from different recording methods, particularly whether the doctors
used paper systems or a computer.
The large number of variables that were eligible for multi-
variable analysis (because of the liberal 10% threshold employed
at the univariable stage) raises the possibility of false positive
associations. The exhaustive, structured, approach to the multi-
variable analyses should have identified such influences. In the
final model, there was a manageable number of variables, all with
very strong evidence of associations both in terms of magnitude
and statistical significance. All of the variables in the final
multivariable model have been reported with colorectal cancer
before. However, in observational epidemiology, residual con-
founding and false positives can never be entirely ruled out.
Symptoms
The level of risk above which investigation is appropriate depends
on the viewpoints of the patient, the doctor and the health care
organisation. The choice of a threshold level for referral has
considerable resource implications, with a lower threshold level
requiring greater provision of investigative services. The percen-
tage of colorectal cancers found in two reports of referrals to 2
week clinics was 9.4 and 16% (Boulton-Jones et al, 2003; Flashman
et al, 2004). This suggests that the Referral Guidelines for
Suspected Cancer – if they were used by the referring doctors –
have a high specificity, but possibly at the cost of a low sensitivity.
Our positive predictive values may be a better guide. We consider a
risk of 2% or more justifies investigation, though many would
argue for a lower threshold.
The positive predictive value of rectal bleeding was 2.4%. This is
less than the 3.3 and 7% reported from two previous primary care
reports, although these studied only 9 and 27 cancers, respectively
(Fijten et al, 1995; Wauters et al, 2000). In patients aged under 70,
the positive predictive value was 1.4%. Rectal bleeding occurred in
4.2% of controls over 2 years, a remarkably similar finding to the
2.1% of the normal population in 1 year previously reported
(Fijten et al, 1993). This also suggests that retrospective use of
primary care records, as in this study, is not associated with an
important loss of data. These figures largely support current UK
Referral Guidelines, which suggest investigation of patients over 60
with persistent rectal bleeding, unaccompanied by local anal
symptoms (Department of Health, 2000). The ICPC code nearest in
meaning to the umbrella term ‘local anal symptoms’ has a slightly
different definition, that of anal/rectal pain. Thus, we were unable
to study if local anal symptoms (which includes other symptoms
such as itching) do indeed reduce the risk that rectal bleeding is
due to cancer, although anal/rectal pain did not appear to do so.
Diarrhoea and constipation were both associated with cancer in
the multivariable analyses. It is debatable whether the predictive
values for diarrhoea of 0.63% in patients under 70, and 1.7% in
those over 70, warrant investigation of this symptom on its own.
However, the presence of any second variable increased the risk
of colorectal cancer to a level when most doctors would consider
investigation. Constipation is less of a risk, supporting the
recommendations in the UK Referral Guidelines (Department of
Health, 2000).
Abdominal pain is a difficult problem for the doctor in primary
care; if anything our results compound this difficulty. It is a very
common symptom, yet it is associated with colorectal cancer.
Furthermore, abdominal pain and rectal bleeding are the two
symptoms that retained their association with the cancer 180 days
Co
ns
tip
at
io
n 
D
ia
rrh
oe
a 
R
ec
ta
l 
bl
ee
di
ng
 
Lo
ss
 o
f 
W
ei
gh
t 
A
bd
om
in
al
 
pa
in
 
A
bd
om
in
al
 
te
nd
er
ne
ss
 
A
bn
or
m
al
 
re
ct
al
 e
xa
m
 
H
ae
m
og
lo
bi
n 
10
 − 
13
 g
 d
l−1
 
H
ae
m
og
lo
bi
n 
<
10
 g
 d
l−1
0.42 
0.3, 
0.5 
0.94 
0.7, 
1.1 
2.4 
1.9, 
3.2 
1.2 
0.9, 
1.6 
1.1 
0.9, 
1.3 
1.1 
0.8, 
1.5 
1.5 
1.0, 
2.2 
0.97
0.8, 
1.3 
2.3 
1.6, 
3.1
PPV as a single 
symptom 
0.81
0.5, 
1.3 
1.1 
0.6, 
1.8 
2.4 
1.4, 
4.4 
3.0 
1.7, 
5.4 
1.5 
1.0, 
2.2 
1.7 
0.9, 
3.4 
2.6 1.2 
0.6, 
2.7 
2.6 Constipation 
1.5 
1.0, 
2.2 
3.4 
2.1, 
6.0 
3.1 
1.8, 
5.5 
1.9 
1.4, 
2.7 
2.4 
1.3, 
4.8 
11 2.2 
1.2, 
4.3 
2.9 Diarrhoea 
6.8 4.7 3.1 
1.9, 
5.3 
4.5 8.5 3.6 3.2 Rectal bleeding 
1.4 
0.8, 
2.6 
3.4 
2.1, 
6.0 
6.4 7.4 1.3 
0.7, 
2.6 
4.7 Loss of weight 
3.0 
1.8, 
5.2 
1.4 
0.3, 
2.2 
3.3 2.2 
1.1, 
4.5 
6.9 Abdominal pain 
1.7 
0.8, 
3.7 
5.8 2.7 >10 Abdominal 
tenderness 
Figure 2 Positive predictive values for colorectal cancer for individual
features, repeat presentations and for pairs of features (in the context of a
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(PPV) for an individual feature. The cells along the diagonal relate to the
PPV when the same feature has been reported twice. Thus, the
constipation/constipation intersect is the PPV for colorectal cancer when
a patient has attended twice (or more often) with constipation. Other cells
show the PPV when a patient has two different features. The top figure in
each cell is the PPV. It has only been calculated when a minimum of 10
cases had the feature or combination of features. The two smaller figures
are the 95% confidence intervals for the PPV. These have not been
calculated when any cell in the 2 2 table was below 10. For haemoglobin
o10 g dl1 with abdominal tenderness, no controls had this pair. It was
scored as a PPV of 410%. The yellow shading is when the PPV is above
1%. The amber shading is when the PPV is above 2.5%, which
approximates to a risk of colorectal cancer of 10 times normal. The red
shading is for PPVs above 5.0% approximating to a risk of 20 times normal.
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before diagnosis. Serious consideration should be given to the
possibility of cancer with abdominal pain and no clear diagnosis.
This would include asking about other symptoms, performing
abdominal and rectal examinations, and testing of faecal occult
blood and haemoglobin. Positive findings on any of these would
suggest referral for investigation of possible colorectal cancer.
Investigations
Anaemia has long been recognised as a feature of colorectal cancer.
Some of the cases in this study had low haemoglobin results more
than a year before eventual diagnosis. Furthermore, haemoglobin
results between 12.0 and 12.9 g dl1 were associated with cancer,
yet some laboratories label results in this range as normal. Doctors
are more likely to investigate anaemia if there are accompanying
symptoms (Yates et al, 2004), and our results confirm that the risk
of cancer with anaemia is indeed higher when symptoms are also
present. However, the predictive value of haemoglobin below
10 g dl1 per se was 2.3%. This supports recommendations that all
patients with iron deficiency anaemia are investigated (Goddard
et al, 2000).
The predictive value of 7.1% for a positive faecal occult blood
test in this study is similar to the 10.9% in those investigated after
a positive test in the UK screening pilot, and mandates
investigation (UK Colorectal Cancer Screening Pilot Group,
2004). This suggests that any bias introduced by selective testing
of patients (as suggested by the figures in the footnote to Table 2)
is small. In any event, such influences would be largely accounted
for by controlling for presenting signs and symptoms in the
multivariable analysis. The antagonistic interaction between a
positive faecal occult blood and severe anaemia probably arises
from the fact that both features represent gastrointestinal bleeding.
Once one of the features is present, the addition of a second one
does not increase the risk as much. The association between raised
glucose and cancer has been reported before in prospective studies
(Trevisan et al, 2001; Saydah et al, 2003). As diabetic patients have
an increased risk of colorectal cancer, consideration has to be
given to the possibility when a patient presents with one of the
other features (Coughlin et al, 2004).
CONCLUSIONS
In patients who have been referred for investigation of possible
colorectal cancer, the predictive values for symptoms are much
higher than in the study reported here (Selvachandran et al, 2002).
For example, rectal bleeding in the referred population had a
positive predictive value of 5.2%, and weight loss 9.4%, compared
with our 2.4 and 1.2%, respectively. Our findings come from
primary care, and should be a more accurate guide for clinicians
who manage unselected patient populations. The positive pre-
dictive values give an initial guide when a single feature, or pair
of features, is present. The implications of combinations of
symptoms can be gleaned from the multivariable analysis. Our
findings can also be used to develop guidelines to select patients
for rapid investigation. There may be as much – or more – benefit
to be achieved from earlier diagnosis of symptomatic colorectal
cancer as from screening for asymptomatic cancer. The two
approaches are complementary. An important minority of colo-
rectal cancers, or their precursors, colorectal polyps, will be
identified by screening at an asymptomatic stage. Symptomatic
patients may benefit from early diagnostic tools used in primary
care, based on the symptoms and investigation findings in this
study. A feasibility study of such a tool begins in 2005, with further
research required to examine its utility.
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